Publications by authors named "Richard Ammer"

Claim this Profile
A
A successful phase space transformation chopper design for neutron backscattering spectroscopy.
Bernhard Frick, Tilo Seydel, Lambert van Eijck, Markus Appel, Jean-François Barthélémy, Richard Ammer

Rev Sci Instrum· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).
Yi Zheng, Huaqing Liu, Xiuxia Wang, Haibo Li, Michaela Ruhmann, Richard Ammer

CNS Drugs· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADHD medicine consumption in Europe after COVID-19: catch-up or trend change?
Sophie Gimbach, Daniel Vogel, Roland Fried, Stephen V Faraone, Tobias Banaschewski, Richard Ammer

BMC Psychiatry· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the real-world safety of two different long-acting methylphenidate formulations (Medikinet MR and Concerta) - a Danish nationwide register-based cohort study.
Jakob Ørnberg, Anke Mayer, Oliver Dangel, Richard Ammer

Scand J Child Adolesc Psychiatr Psychol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients.
Daniela Egli-Spichtig, Ahmad Kamal Hamid, Eva Maria Pastor Arroyo, Markus Ketteler, Andrzej Wiecek, Richard Ammer

Clin Kidney J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions.
Sophie Gimbach, Daniel Vogel, Roland Fried, Stephen V Faraone, Tobias Banaschewski, Richard Ammer

Eur Neuropsychopharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase 3 randomized controlled NOPHOS trial.
Markus Ketteler, Andrzej Wiecek, Alexander R Rosenkranz, Claudia Ose, Jan Rekowski, Richard Ammer

Nephrol Dial Transplant· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial.
Markus Ketteler, Andrzej Wiecek, Alexander R Rosenkranz, Andreas Pasch, Jan Rekowski, Richard Ammer

Kidney Int Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylphenidate treatment of adult ADHD patients improves the degree of ADHD severity under routine conditions.
Wolfgang Retz, Michael Rösler, Roland Fischer, Claudia Ose, Richard Ammer

J Neural Transm (Vienna)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidate.
Wolfgang Retz, Michael Rösler, Claudia Ose, André Scherag, Barbara Alm, Richard Ammer

World J Biol Psychiatry· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention-deficit/hyperactivity disorder in a natural setting: comparison of the efficacy of Medikinet(®) retard and Concerta(®)--a randomized, controlled, double-blind multicenter clinical crossover trial.
Manfred Döpfner, Claudia Ose, Roland Fischer, Richard Ammer, André Scherag

J Child Adolesc Psychopharmacol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD.
Michael Rösler, Wolfgang Retz, Roland Fischer, Claudia Ose, Barbara Alm, Richard Ammer

World J Biol Psychiatry· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.
Michael Rösler, Roland Fischer, Richard Ammer, Claudia Ose, Wolfgang Retz

Eur Arch Psychiatry Clin Neurosci· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human lymph node in vitro--challenges and progress.
Christoph Giese, Christian D Demmler, Richard Ammer, Stefan Hartmann, Annika Lubitz

Artif Organs· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Atrial fibrillation: molecular biology bases].
Wilhelm Haverkamp, Richard Ammer, Paulus Kirchhof, Lars Eckardt, Larissa Fabritz

Herz· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis